Real Time Insider Transaction Data
Real Time Insider buys and sells Data - Insider Trades - Insider Transactions - Insider Trading Data - SEC Form 4 Data
Total | Transactions | Amount |
Buys | 0 | $0 |
Sells | 216 | $64,676,564 |
Security | Reporting Name | Relationship | Purchase/Sale | Shares | Price $ | D/I | ||||
17 Aug 2022 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 15 Aug 2022 | Sale | 1,218 | 228.33 | 278,106 | D |
17 Aug 2022 16:07 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 15 Aug 2022 | Sale | 98 | 226.16 | 22,164 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 104 | 225.15 | 23,416 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 5 | 224 | 1,120 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 105 | 220.95 | 23,200 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 99 | 219.53 | 21,733 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 541 | 218.71 | 118,322 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 440 | 217.61 | 95,748 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 398 | 216.21 | 86,052 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Aug 2022 | Sale | 149 | 215.03 | 32,039 | D |
05 Aug 2022 16:15 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 03 Aug 2022 | Sale | 1,754 | 210 | 368,340 | D |
07 Jul 2022 16:06 | ALNY | ALNYLAM PHARMACEUTICALS Inc | TANGULER TOLGA | EVP, Chief Commercial Officer | 05 Jul 2022 | Sale | 1,754 | 150 | 263,100 | D |
01 Mar 2024 16:12 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 29 Feb 2024 | Sale | 1,906 | 153.62 | 292,800 | D |
01 Mar 2024 16:12 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 29 Feb 2024 | Sale | 915 | 152.4 | 139,446 | D |
01 Mar 2024 16:12 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 29 Feb 2024 | Sale | 13,557 | 151.43 | 2,052,937 | D |
01 Mar 2024 16:12 | ALNY | ALNYLAM PHARMACEUTICALS Inc | SHARP PHILLIP A | Director | 29 Feb 2024 | Sale | 13,005 | 150.6 | 1,958,553 | D |
* D/I = Direct / Indirect
* 10% = Entity with 10% or higher ownership stake
* A = Amendment Filing (SEC Form 4/A)